Cargando…

Molecular pharmacology of ciclesonide against SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Kimura, Hirokazu, Kurusu, Hiromu, Sada, Mitsuru, Kurai, Daisuke, Murakami, Koichi, Kamitani, Wataru, Tomita, Haruyoshi, Katayama, Kazuhiko, Ryo, Akihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7293530/ https://www.ncbi.nlm.nih.gov/pubmed/32593491 http://dx.doi.org/10.1016/j.jaci.2020.05.029

Ejemplares similares

Molecular Evolution of the Pseudomonas aeruginosa DNA Gyrase gyrA Gene
por: Sada, Mitsuru, et al.
Publicado: (2022)

Detailed Molecular Interactions of Favipiravir with SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza Virus Polymerases In Silico
por: Sada, Mitsuru, et al.
Publicado: (2020)

Molecular Evolutionary Analyses of the Spike Protein Gene and Spike Protein in the SARS-CoV-2 Omicron Subvariants
por: Nagasawa, Norika, et al.
Publicado: (2023)

The Inhaled Steroid Ciclesonide Blocks SARS-CoV-2 RNA Replication by Targeting the Viral Replication-Transcription Complex in Cultured Cells
por: Matsuyama, Shutoku, et al.
Publicado: (2020)

Molecular Evolutionary Analyses of the Pseudomonas-Derived Cephalosporinase Gene
por: Shirai, Tatsuya, et al.
Publicado: (2023)

Detailed Analyses of Molecular Interactions between Favipiravir and RNA Viruses In Silico
por: Shirai, Tatsuya, et al.
Publicado: (2022)

All-Trans Retinoic Acid Exhibits Antiviral Effect against SARS-CoV-2 by Inhibiting 3CLpro Activity
por: Morita, Takeshi, et al.
Publicado: (2021)

Editorial for the Special Issue: Molecular Epidemiology, Diagnostics and Management of Respiratory Virus Infections
por: Kimura, Hirokazu, et al.
Publicado: (2020)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

Ciclesonide for the treatment of asthma
por: Dahl, Ronald
Publicado: (2006)

Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication
por: Tsuji, Genichiro, et al.
Publicado: (2022)

Ciclesonide/iguratimod: Prolonged presence of SARS-CoV-2: case report
Publicado: (2020)

Development of ciclesonide analogues that block SARS-CoV-2 RNA replication
por: Tsuji, Genichiro, et al.
Publicado: (2021)

Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008)

Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa
por: Sato, Hideyuki, et al.
Publicado: (2007)

Frequent occurrence of mutations in nsp3 and nsp4 of SARS-CoV-2, presumably caused by the inhaled asthma drug ciclesonide
por: Doi, Akihiro, et al.
Publicado: (2022)

Adsorption of Phenazines Produced by Pseudomonas aeruginosa Using AST-120 Decreases Pyocyanin-Associated Cytotoxicity
por: Hirakawa, Hidetada, et al.
Publicado: (2021)

Molecular Evolution of the Fusion Protein (F) Gene in Human Respirovirus 3
por: Aso, Jumpei, et al.
Publicado: (2020)

Molecular Evolutionary Analyses of the RNA-Dependent RNA Polymerase (RdRp) Region and VP1 Gene in Human Norovirus Genotypes GII.P6-GII.6 and GII.P7-GII.6
por: Takahashi, Tomoko, et al.
Publicado: (2023)

A Macroporous Magnesium Oxide-Templated Carbon Adsorbs Shiga Toxins and Type III Secretory Proteins in Enterohemorrhagic Escherichia coli, Which Attenuates Virulence
por: Hirakawa, Hidetada, et al.
Publicado: (2022)

Profile of ciclesonide for the maintenance treatment of asthma
por: Singas, Effie, et al.
Publicado: (2011)

Molecular Evolution of the Protease Region in Norovirus Genogroup II
por: Ozaki, Keita, et al.
Publicado: (2020)

Rhinovirus Infection and Virus-Induced Asthma
por: Hayashi, Yuriko, et al.
Publicado: (2022)

Detailed Molecular Interactions between Respiratory Syncytial Virus Fusion Protein and the TLR4/MD-2 Complex In Silico
por: Akagawa, Mao, et al.
Publicado: (2022)

Prolonged presence of SARS-CoV-2 in a COVID-19 case with rheumatoid arthritis taking iguratimod treated with ciclesonide()
por: Baba, Hiroaki, et al.
Publicado: (2020)

Efficacy of ciclesonide in the treatment of patients with asthma exacerbation
por: Zietkowski, Ziemowit, et al.
Publicado: (2019)

Molecular evolutionary analyses of the fusion protein gene in human respirovirus 1
por: Takahashi, Tomoko, et al.
Publicado: (2023)

Ruxolitinib inhibits poly(I:C) and type 2 cytokines‐induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma
por: Sada, Mitsuru, et al.
Publicado: (2021)

Molecular Evolutionary Analyses of the RNA-Dependent RNA Polymerase Region in Norovirus Genogroup II
por: Ozaki, Keita, et al.
Publicado: (2018)

The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide
por: Yamasaki, Yukitaka, et al.
Publicado: (2020)

Ciclesonide in persistent asthma: the evidence of its therapeutic value
por: Kenreigh, Charlotte A., et al.
Publicado: (2006)

A Case of Coronavirus Disease 2019 Treated With Ciclesonide
por: Nakajima, Kento, et al.
Publicado: (2020)

Is there a role for inhaled ciclesonide in the treatment of COVID-19?
por: Salvi, Sundeep Santosh
Publicado: (2021)

Pathogen profiles and molecular epidemiology of respiratory viruses in Japanese inpatients with community-acquired pneumonia
por: Kurai, Daisuke, et al.
Publicado: (2016)

Complete Genome Sequence of a Recombinant GII.P16-GII.4 Norovirus Detected in Kawasaki City, Japan, in 2016
por: Matsushima, Yuki, et al.
Publicado: (2016)

Pathophysiology and epidemiology of virus-induced asthma
por: Kimura, Hirokazu, et al.
Publicado: (2014)

Metabolism of ciclesonide in the upper and lower airways: review of available data
por: Nave, Ruediger, et al.
Publicado: (2008)

Ciclesonide: a safe and effective inhaled corticosteroid for the treatment of asthma
por: Schaffner, Timothy J, et al.
Publicado: (2009)

Inhaled ciclesonide for outpatients with COVID-19: A meta-analysis
por: Hsu, Chi-Kuei, et al.
Publicado: (2022)

A randomized, double-blind study comparing the efficacy and safety of a combination of formoterol and ciclesonide with ciclesonide alone in asthma subjects with moderate-to-severe airflow limitation
por: Salvi, Sundeep S, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h0d76gf79pn6ber1ljs1qp6ad6